Reports for METHYLPHENIDATE HYDROCHLORIDE

Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOQUEST 35MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-08-08 2023-08-18 201413
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-23 196297
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-07-21 2023-08-28 199441
FOQUEST 70MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-08-16 2023-08-28 201903
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-09-13 2023-09-23 204210
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-09-07 2023-09-23 203858
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
APO-METHYLPHENIDATE 10MG TABLET Resolved 2023-09-07 2023-10-20 203812
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400

Showing 171 to 180 of 198

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHYLPHENIDATE 5MG TABLET Discontinued 2019-04-10 2019-04-11 81132
METHYLPHENIDATE 10MG TABLET Discontinued 2019-04-10 2019-04-11 81136
METHYLPHENIDATE 20MG TABLET Discontinued 2019-04-10 2019-04-11 81139
RITALIN 20MG 20MG TABLET Discontinued 2019-07-22 2019-08-01 89771
PMS-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118099
PMS-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118102
PMS-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118105
PMS-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118108
RITALIN-SR TAB 20MG 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-02-08 2022-04-05 154439
RITALIN 10MG 10MG TABLET Discontinued 2022-02-08 2022-05-11 154449

Showing 1 to 10 of 11